ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
1 report, 1 independent
Updated Sep 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
MarketBeat
American personal finance blog
Related events
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- Adtran and NetScout Systems are listed on NASDAQ and are being compared on financial metrics with analyst recommendations reported.
- ProKidney and Lyell Immunopharma were listed on the NASDAQ stock exchange on August 1, 2026.
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.